Department of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, Korea.
Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida 201313, India.
Int J Mol Sci. 2019 May 18;20(10):2468. doi: 10.3390/ijms20102468.
Multiple drug-resistant bacteria are a severe and growing public health concern. Because relatively few antibiotics have been approved over recent years and because of the inability of existing antibiotics to combat bacterial infections fully, demand for unconventional biocides is intense. Metallic nanoparticles (NPs) offer a novel potential means of fighting bacteria. Although metallic NPs exert their effects through membrane protein damage, superoxide radicals and the generation of ions that interfere with the cell granules leading to the formation of condensed particles, their antimicrobial potential, and mechanisms of action are still debated. This article discusses the action of metallic NPs as antibacterial agents, their mechanism of action, and their effect on bacterial drug resistance. Based on encouraging data about the antibacterial effects of NP/antibiotic combinations, we propose that this concept be thoroughly researched to identify means of combating drug-resistant bacteria.
多重耐药菌是一个严重且日益严重的公共卫生问题。由于近年来批准的抗生素相对较少,并且由于现有抗生素无法完全对抗细菌感染,因此对非传统杀生物剂的需求非常强烈。金属纳米颗粒 (NPs) 提供了一种新型的抗菌方法。尽管金属 NPs 通过破坏膜蛋白、超氧自由基和生成干扰细胞颗粒的离子来发挥作用,导致凝聚颗粒的形成,但它们的抗菌潜力和作用机制仍存在争议。本文讨论了金属 NPs 作为抗菌剂的作用、作用机制以及它们对细菌耐药性的影响。基于 NP/抗生素组合的抗菌效果的令人鼓舞的数据,我们建议彻底研究这一概念,以寻找对抗耐药菌的方法。